These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34387088)

  • 61. New Synthetic Routes to Triazolo-benzodiazepine Analogues: Expanding the Scope of the Bump-and-Hole Approach for Selective Bromo and Extra-Terminal (BET) Bromodomain Inhibition.
    Baud MG; Lin-Shiao E; Zengerle M; Tallant C; Ciulli A
    J Med Chem; 2016 Feb; 59(4):1492-500. PubMed ID: 26367539
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Discovery of 1-(5-(1H-benzo[d]imidazole-2-yl)-2,4-dimethyl-1H-pyrrol-3-yl)ethan-1-one derivatives as novel and potent bromodomain and extra-terminal (BET) inhibitors with anticancer efficacy.
    Kong B; Zhu Z; Li H; Hong Q; Wang C; Ma Y; Zheng W; Jiang F; Zhang Z; Ran T; Bian Y; Yang N; Lu T; Zhu J; Tang W; Chen Y
    Eur J Med Chem; 2022 Jan; 227():113953. PubMed ID: 34731760
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains.
    Fedorov O; Lingard H; Wells C; Monteiro OP; Picaud S; Keates T; Yapp C; Philpott M; Martin SJ; Felletar I; Marsden BD; Filippakopoulos P; Müller S; Knapp S; Brennan PE
    J Med Chem; 2014 Jan; 57(2):462-76. PubMed ID: 24313754
    [TBL] [Abstract][Full Text] [Related]  

  • 64. BET Bromodomain Inhibition as a Therapeutic Strategy in Ovarian Cancer by Downregulating FoxM1.
    Zhang Z; Ma P; Jing Y; Yan Y; Cai MC; Zhang M; Zhang S; Peng H; Ji ZL; Di W; Gu Z; Gao WQ; Zhuang G
    Theranostics; 2016; 6(2):219-30. PubMed ID: 26877780
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Advancements in the Development of non-BET Bromodomain Chemical Probes.
    Clegg MA; Tomkinson NCO; Prinjha RK; Humphreys PG
    ChemMedChem; 2019 Feb; 14(4):362-385. PubMed ID: 30624862
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Identification of a novel series of BET family bromodomain inhibitors: binding mode and profile of I-BET151 (GSK1210151A).
    Seal J; Lamotte Y; Donche F; Bouillot A; Mirguet O; Gellibert F; Nicodeme E; Krysa G; Kirilovsky J; Beinke S; McCleary S; Rioja I; Bamborough P; Chung CW; Gordon L; Lewis T; Walker AL; Cutler L; Lugo D; Wilson DM; Witherington J; Lee K; Prinjha RK
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2968-72. PubMed ID: 22437115
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Design and development of a novel series of oral bivalent BET inhibitors with potent anticancer activities.
    Luo M; Wu Q; Yang Y; Sun L; Huan X; Tian C; Xiong B; Miao Z; Wang Y; Chen D
    Eur J Med Chem; 2022 Sep; 239():114519. PubMed ID: 35714446
    [TBL] [Abstract][Full Text] [Related]  

  • 68. AZD5153: A Novel Bivalent BET Bromodomain Inhibitor Highly Active against Hematologic Malignancies.
    Rhyasen GW; Hattersley MM; Yao Y; Dulak A; Wang W; Petteruti P; Dale IL; Boiko S; Cheung T; Zhang J; Wen S; Castriotta L; Lawson D; Collins M; Bao L; Ahdesmaki MJ; Walker G; O'Connor G; Yeh TC; Rabow AA; Dry JR; Reimer C; Lyne P; Mills GB; Fawell SE; Waring MJ; Zinda M; Clark E; Chen H
    Mol Cancer Ther; 2016 Nov; 15(11):2563-2574. PubMed ID: 27573426
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Identification and Optimization of a Ligand-Efficient Benzoazepinone Bromodomain and Extra Terminal (BET) Family Acetyl-Lysine Mimetic into the Oral Candidate Quality Molecule I-BET432.
    Humphreys PG; Anderson NA; Bamborough P; Baxter A; Chung CW; Cookson R; Craggs PD; Dalton T; Fournier JCL; Gordon LJ; Gray HF; Gray MW; Gregory R; Hirst DJ; Jamieson C; Jones KL; Kessedjian H; Lugo D; McGonagle G; Patel VK; Patten C; Poole DL; Prinjha RK; Ramirez-Molina C; Rioja I; Seal G; Stafford KAJ; Shah RR; Tape D; Theodoulou NH; Tomlinson L; Ukuser S; Wall ID; Wellaway N; White G
    J Med Chem; 2022 Nov; 65(22):15174-15207. PubMed ID: 36378954
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Suppression of interferon β gene transcription by inhibitors of bromodomain and extra-terminal (BET) family members.
    Malik N; Vollmer S; Nanda SK; Lopez-Pelaez M; Prescott A; Gray N; Cohen P
    Biochem J; 2015 Jun; 468(3):363-72. PubMed ID: 25891802
    [TBL] [Abstract][Full Text] [Related]  

  • 71. RVX-297- a novel BD2 selective inhibitor of BET bromodomains.
    Kharenko OA; Gesner EM; Patel RG; Norek K; White A; Fontano E; Suto RK; Young PR; McLure KG; Hansen HC
    Biochem Biophys Res Commun; 2016 Aug; 477(1):62-67. PubMed ID: 27282480
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Methylpyrrole inhibitors of BET bromodomains.
    Hasvold LA; Sheppard GS; Wang L; Fidanze SD; Liu D; Pratt JK; Mantei RA; Wada CK; Hubbard R; Shen Y; Lin X; Huang X; Warder SE; Wilcox D; Li L; Buchanan FG; Smithee L; Albert DH; Magoc TJ; Park CH; Petros AM; Panchal SC; Sun C; Kovar P; Soni NB; Elmore SW; Kati WM; McDaniel KF
    Bioorg Med Chem Lett; 2017 May; 27(10):2225-2233. PubMed ID: 28268136
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Identification of a Chemical Probe for Family VIII Bromodomains through Optimization of a Fragment Hit.
    Gerstenberger BS; Trzupek JD; Tallant C; Fedorov O; Filippakopoulos P; Brennan PE; Fedele V; Martin S; Picaud S; Rogers C; Parikh M; Taylor A; Samas B; O'Mahony A; Berg E; Pallares G; Torrey AD; Treiber DK; Samardjiev IJ; Nasipak BT; Padilla-Benavides T; Wu Q; Imbalzano AN; Nickerson JA; Bunnage ME; Müller S; Knapp S; Owen DR
    J Med Chem; 2016 May; 59(10):4800-11. PubMed ID: 27115555
    [TBL] [Abstract][Full Text] [Related]  

  • 74. NF-κB signaling activation via increases in BRD2 and BRD4 confers resistance to the bromodomain inhibitor I-BET151 in U937 cells.
    Hishiki K; Akiyama M; Kanegae Y; Ozaki K; Ohta M; Tsuchitani E; Kaito K; Yamada H
    Leuk Res; 2018 Nov; 74():57-63. PubMed ID: 30300821
    [TBL] [Abstract][Full Text] [Related]  

  • 75. BET bromodomain ligands: Probing the WPF shelf to improve BRD4 bromodomain affinity and metabolic stability.
    Jennings LE; Schiedel M; Hewings DS; Picaud S; Laurin CMC; Bruno PA; Bluck JP; Scorah AR; See L; Reynolds JK; Moroglu M; Mistry IN; Hicks A; Guzanov P; Clayton J; Evans CNG; Stazi G; Biggin PC; Mapp AK; Hammond EM; Humphreys PG; Filippakopoulos P; Conway SJ
    Bioorg Med Chem; 2018 Jul; 26(11):2937-2957. PubMed ID: 29776834
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Mapping the chemical chromatin reactivation landscape identifies BRD4-TAF1 cross-talk.
    Sdelci S; Lardeau CH; Tallant C; Klepsch F; Klaiber B; Bennett J; Rathert P; Schuster M; Penz T; Fedorov O; Superti-Furga G; Bock C; Zuber J; Huber KV; Knapp S; Müller S; Kubicek S
    Nat Chem Biol; 2016 Jul; 12(7):504-10. PubMed ID: 27159579
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Preparation and antiarthritic and analgesic activity of 4,5-diaryl-2-(substituted thio)-1H-imidazoles and their sulfoxides and sulfones.
    Sharpe TR; Cherkofsky SC; Hewes WE; Smith DH; Gregory WA; Haber SB; Leadbetter MR; Whitney JG
    J Med Chem; 1985 Sep; 28(9):1188-94. PubMed ID: 3875725
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Discovery of a Small-Molecule Degrader of Bromodomain and Extra-Terminal (BET) Proteins with Picomolar Cellular Potencies and Capable of Achieving Tumor Regression.
    Zhou B; Hu J; Xu F; Chen Z; Bai L; Fernandez-Salas E; Lin M; Liu L; Yang CY; Zhao Y; McEachern D; Przybranowski S; Wen B; Sun D; Wang S
    J Med Chem; 2018 Jan; 61(2):462-481. PubMed ID: 28339196
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.
    Lambert JP; Picaud S; Fujisawa T; Hou H; Savitsky P; Uusküla-Reimand L; Gupta GD; Abdouni H; Lin ZY; Tucholska M; Knight JDR; Gonzalez-Badillo B; St-Denis N; Newman JA; Stucki M; Pelletier L; Bandeira N; Wilson MD; Filippakopoulos P; Gingras AC
    Mol Cell; 2019 Feb; 73(3):621-638.e17. PubMed ID: 30554943
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Discovery of novel small-molecule inhibitors of BRD4 using structure-based virtual screening.
    Vidler LR; Filippakopoulos P; Fedorov O; Picaud S; Martin S; Tomsett M; Woodward H; Brown N; Knapp S; Hoelder S
    J Med Chem; 2013 Oct; 56(20):8073-88. PubMed ID: 24090311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.